Jasper Therapeutics, Inc.

JSPR

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/14/26 10-K/AFY 202504/30/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/10/25

Disclosures

8-KCurrent report10/15/26 8-KCurrent report10/07/26 8-KCurrent report10/05/26 8-K/ACurrent report (amended)10/05/26 8-K/ACurrent report (amended)10/01/26

Prospectuses and Registrations

S-3Shelf registration10/14/26 424B5Prospectus supplement09/19/25 424B5Prospectus supplement09/18/25 424B5Prospectus supplement03/26/25 S-3Shelf registration03/19/25

Proxies

DEF 14ADefinitive proxy10/19/26 PRE 14APreliminary proxy10/09/26 DEF 14ADefinitive proxy09/04/26 PRE 14APreliminary proxy08/24/26 DEF 14ADefinitive proxy06/15/26

Ownership

SC 13GBeneficial ownership08/17/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26

Other

SC TO-I/ASC TO-I/A10/23/26 SC TO-IIssuer tender offer10/07/26 25-NSERemoval from listing09/24/26 DD08/05/26 ARSAnnual report to shareholders06/15/26